Monday, April 24, 2017

Oncogenesis - Table of Contents alert Volume 6, April 2017



September 17-19, 2017 | Seattle, WA, USA

Presented by: Adaptive Biotechnologies | Nature Immunology | Nature Medicine | Nature Biotechnology



Volume 6, April 2017

In this issue
Original Articles
Short Communication
A supplement to
Nature Biotechnology | Nature Reviews Drug Discovery

Check out the latest issue of BioPharma Dealmakers for the latest dealmaking opportunities, and editorials on personalized cancer vaccines based on tumor-specific neoantigens, the expanding network of microbiome partnerships, and impending growth spurt of the dermatology market.

Download the issue for FREE
Sign up for e-alerts Sign up for e-alerts
Web feed



Wnt signaling in triple-negative breast cancer

SÖ-G Pohl, N Brook, M Agostino, F Arfuso, A P Kumar and A Dharmarajan

Oncogenesis 2017 6: e310; 10.1038/oncsis.2017.14

Abstract | Full Text

Original Articles


Initial sites of hepadnavirus integration into host genome in human hepatocytes and in the woodchuck model of hepatitis B-associated hepatocellular carcinoma

R Chauhan, N D Churchill, P M Mulrooney-Cousins and T I Michalak

Oncogenesis 2017 6: e317; 10.1038/oncsis.2017.22

Abstract | Full Text

MET amplification and epithelial-to-mesenchymal transition exist as parallel resistance mechanisms in erlotinib-resistant, EGFR-mutated, NSCLC HCC827 cells

K R Jakobsen, C Demuth, A T Madsen, D Hussmann, J Vad-Nielsen, A L Nielsen and B S Sorensen

Oncogenesis 2017 6: e307; 10.1038/oncsis.2017.17

Abstract | Full Text

MAGE-TRIM28 complex promotes the Warburg effect and hepatocellular carcinoma progression by targeting FBP1 for degradation

X Jin, Y Pan, L Wang, L Zhang, R Ravichandran, P R Potts, J Jiang, H Wu and H Huang

Oncogenesis 2017 6: e312; 10.1038/oncsis.2017.21

Abstract | Full Text

Methylation of WNT target genes AXIN2 and DKK1 as robust biomarkers for recurrence prediction in stage II colon cancer

R Kandimalla, J F Linnekamp, S van Hooff, A Castells, X Llor, M Andreu, R Jover, A Goel and J P Medema

Oncogenesis 2017 6: e308; 10.1038/oncsis.2017.9

Abstract | Full Text

Inhibition of DNA2 nuclease as a therapeutic strategy targeting replication stress in cancer cells

S Kumar, X Peng, J Daley, L Yang, J Shen, N Nguyen, G Bae, H Niu, Y Peng, H-J Hsieh, L Wang, C Rao, C C Stephan, P Sung, G Ira and G Peng

Oncogenesis 2017 6: e319; 10.1038/oncsis.2017.15

Abstract | Full Text

CRB3 downregulation confers breast cancer stem cell traits through TAZ/β-catenin

P Li, Y Wang, X Mao, Y Jiang, J Liu, J Li, J Wang, R Wang, J She, J Zhang, J Yang, Y Liu and P Liu

Oncogenesis 2017 6: e322; 10.1038/oncsis.2017.24

Abstract | Full Text

p16 controls epithelial cell growth and suppresses carcinogenesis through mechanisms that do not require RB1 function

M Sen, N Akeno, A Reece, A L Miller, D S Simpson and K A Wikenheiser-Brokamp

Oncogenesis 2017 6: e320; 10.1038/oncsis.2017.5

Abstract | Full Text

Oncogenic MCT-1 activation promotes YY1-EGFR-MnSOD signaling and tumor progression

H-Y Tseng, Y-A Chen, J Jen, P-C Shen, L-M Chen, T-D Lin, Y-C Wang and H-L Hsu

Oncogenesis 2017 6: e313; 10.1038/oncsis.2017.13

Abstract | Full Text

Loss of LZAP inactivates p53 and regulates sensitivity of cells to DNA damage in a p53-dependent manner

J J Wamsley, C Gary, A Biktasova, M Hajek, G Bellinger, R Virk, N Issaeva and W G Yarbrough

Oncogenesis 2017 6: e314; 10.1038/oncsis.2017.12

Abstract | Full Text

TCRP1 promotes NIH/3T3 cell transformation by over-activating PDK1 and AKT1

C Wang, H Liu, Q Qiu, Z Zhang, Y Gu and Z He

Oncogenesis 2017 6: e323; 10.1038/oncsis.2017.18

Abstract | Full Text

The pleiotropic regulation of cyclin D1 by newly identified sesaminol-binding protein ANT2

M Watanabe, Y Iizumi, M Sukeno, M Iizuka-Ohashi, Y Sowa and T Sakai

Oncogenesis 2017 6: e311; 10.1038/oncsis.2017.10

Abstract | Full Text

Twist1/Dnmt3a and miR186 establish a regulatory circuit that controls inflammation-associated prostate cancer progression

X Zhao, R Deng, Y Wang, H Zhang, J Dou, L Li, Y Du, R Chen, J Cheng and J Yu

Oncogenesis 2017 6: e315; 10.1038/oncsis.2017.16

Abstract | Full Text

Short Communication


p53 targets TSPAN8 to prevent invasion in melanoma cells

G Agaësse, L Barbollat-Boutrand, M El Kharbili, O Berthier-Vergnes and I Masse

Oncogenesis 2017 6: e309; 10.1038/oncsis.2017.11

Abstract | Full Text



A natural food sweetener with anti-pancreatic cancer properties

C Liu, L-H Dai, D-Q Dou, L-Q Ma and Y-X Sun

Oncogenesis 2017 6: e316; 10.1038/oncsis.2017.19

Full Text

MiR-186 inhibited aerobic glycolysis in gastric cancer via HIF-1α regulation

L Liu, Y Wang, R Bai, K Yang and Z Tian

Oncogenesis 2017 6: e318; 10.1038/oncsis.2017.20

Full Text

An online-only, open access, multidisciplinary journal dedicated to publishing high-quality original research articles, reviews, editorials, commentaries, and hypothesis generating observations on all areas of breast cancer research. Part of the Nature Partner Journals series, published in partnership with the Breast Cancer Research Foundation. 

Now open for submissions >> 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on For event advertising opportunities across the Nature Publishing Group portfolio please contact
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogenesis. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your account at: (You will need to log in to be recognised as a registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature

No comments: